ZimVie to Announce Q2 Results July 30
ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced it will report financial results for the second quarter
ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced it will report financial results for the second quarter
ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced the launch of its RealGUIDE® Software Suite and Implant
ZimVie Inc. (Nasdaq: ZIMV), a global leader in life sciences and dental technology, has announced its financial results for the first quarter of 2025, highlighting

ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, recently announced it will report financial results for the first quarter of
(Image: Screenshot from ZimVie’s promotional video) ZimVie has launched its immediate molar implant system in the US. ZimVie is expanding its TSX and T3 PRO implant systems

ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced the publication of a detailed scientific study demonstrating the surface

ZimVie recently announced that management will participate in the upcoming UBS Global Healthcare Conference. Management will be presenting on Tuesday, November 12, 2024 at 3:30
ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, announced that it will report financial results for the third quarter of

ZimVie announced the U.S. launch of its GenTek Genuine Restorative Components product portfolio. The launch expands ZimVie’s portfolio of end-to-end prosthetic offerings and follows the

ZimVie announced management will participate in the upcoming 23rd Annual Needham Virtual Healthcare Conference. Management will be presenting on Wednesday, April 10th, 2024, at 3:00

ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the fourth quarter

ZimVie announced its debut as an independent publicly traded company and the completion of its separation from Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH).